Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine

European Journal of Clinical Pharmacology

Volumn 50, Issue 4, 1996, Pages 327-333

  Chosidow, O ^a   Dubruc, C ^b   Danjou, P ^b,d   Fuseau, E ^b,e   Espagne, E ^c   Bianchetti, G ^b   Thenot, J P ^b   Herson, S ^a   Rosenzweig, P ^b   Revuz, J ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SANOFI   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Division Wyeth Ayerst Research   (France)

^e GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antihistamine; H1 receptor antagonist; Histamine induced wheal and flare; Mizolastine; Skin suction blister fluid

Indexed keywords

MIZOLASTINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLISTER; CLINICAL TRIAL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PREDICTION; PRIORITY JOURNAL; SIMULATION; URTICARIA; VOLUNTEER;

ADMINISTRATION, ORAL; ADULT; BENZIMIDAZOLES; BLISTER; BODY WATER; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY; MALE;

EID: 8944262044     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050117     Document Type: Article

References (20)

1. 1-receptor antagonist properties (abstr). Eur J Clin Pharmacol 183:218
2. 1-receptor antagonist SL 85.0324 in the rat and guinea pig (abstr). Eur J Clin Pharmacol 183:222
3. 1 antihistamine. Ann Allergy 69:135-139
4. Stern MA, Dunmore CJ, Théron M (1990) A double-blind comparative study of mizolastine (SL 85.0324) 10 mg and placebo in the treatment of seasonal allergic rhinoconjunctivitis in adult patients (abstr). Eur J All Clin Immun 47:12
5. Herfst MJ, Van Rees H (1978) Suction blister fluid as a model for interstitial fluid in rats. Arch Dermatol Res 263:325-334
6. Kiistala U (1968) Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 50:129-137
7. Solberg CO, Halstensen A, Digranes A, Hellum KB (1983) Penetration of antibiotics into human leukocytes and dermal suction blisters. Rev Infect Dis 5:S468-S473
8. Lauharanta J, Paravicine U (1982) Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis. Arch Dermatol Res 272:147-149
9. Lauharanta J, Juvakoski T, Kanerva L, Lassus A (1982) Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. Arch Dermatol Res 273:111-114
10. Hüther KJ, Renftle G, Barraud N, Burke JT, Koch-Weser J (1977) Inhibitory activity of terfenadine on histamine-induced skin wheals in man. Eur J Clin Pharmacol 12:195-199
11. Schäfer-Korting M, Korting HC, Hiemstra S, Mutschler E (1982): Does cantharides blister fluid provide access to the peripheral compartment? Eur J Clin Pharmacol 23:327-330
12. Wise R (1981) Plasma protein binding of drugs. BMJ 282: 1707-1708
13. Stalder JF, Dreno B, Litoux P (1987): Bulles de succion. Techniques et applications. Ann Dermatol Vénéréol 114: 421-423
14. 1-receptor-antagonist drugs. N Engl J Med 330: 1663-1670
15. 1 antihistamine (abstr). 96th annual meeting of the American Society for Clinical Pharmacology and Therapeutics, March 15-17, San Diego, California, USA
16. Mouton JW, Horrevorts AM, Mulder PGH, Prens EP, Michel MF (1990) Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob Agents Chemother 34:2307-2311
17. Vaillant L, Machet L, Taburet AM, Sorensen H, Lorette G (1992) Levels of fusidic acid in skin blister fluid and serum after repeated administration of two dosages (250 and 500 mg). Br J Dermatol 126:591-595
18. 1-antihistamines. Clin Pharmacokinet 28:419-432
19. Shall L, Newcombe RG, Lush M, Marks R (1991) Dose-response relationship between objective measures of histamine-induced wheals and dose of terfenadine. Acta Derm Venereol (Stockh) 71:199-204
20. Haneke E (1990) Fluconazole levels in human epidermis and blister fluid. Br J Dermatol 123:273-274